The August issue of JVIR is well worth perusing for both beginning and experienced interventional oncologists. Ryan Hickey’s primers on Cancer Concepts and Principles provide a thorough introductory background for IR Fellows and early practitioners. Busy practitioners will appreciate
There was some great science at SIR this year. I found the abstract session on radioembolization particularly thought-provoking. A series of presentations from Marnix Lam (catch his lecture at WCIO this New York this month!) examined dose distribution following resin-based radioembolization...
One of my NP’s presented a new consult to me this week: 15cm central HCC, wheelchair bound, heart and renal failure, blistering wounds on the legs from severe edema requiring daily dressing changes and whirlpool therapy for debridement...you get the picture. She advised me not to treat him.
The IO Central Chemoembolization Discussion Group this week raised the issue of getting insurance approval for atypical tumors. Not surprisingly, the insurer in this case turned out to be Blue Cross, one of the worst carriers for Interventional Oncology procedures.
The “What is an IO Practice?” blog (Sept. 24) stimulated a lively discussion among European practitioners on WCIO’ s Linked In site about the challenges carving out an identity for IO. From Germany, to Greece, to Serbia, common themes included